Health Catalyst, Inc. — Director's Dealing 2021

Dec 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-12-02

Reporting Person: Burton Daniel D. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-02	Common Stock	F	4410.00	$41.9475	Disposed	241871.00	Direct
2021-12-03	Common Stock	M	21781.00	$10.80	Acquired	263652.00	Direct
2021-12-03	Common Stock	M	14431.00	$15.84	Acquired	278083.00	Direct
2021-12-03	Common Stock	S	25885.00	$40.2787	Disposed	252198.00	Direct
2021-12-03	Common Stock	S	10127.00	$41.4684	Disposed	242071.00	Direct
2021-12-03	Common Stock	S	200.00	$42.1299	Disposed	241871.00	Direct
2021-12-06	Common Stock	M	11126.00	$10.80	Acquired	252997.00	Direct
2021-12-06	Common Stock	M	5881.00	$15.84	Acquired	258878.00	Direct
2021-12-06	Common Stock	S	21972.00	$40.0617	Disposed	236906.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-03	Stock Option (Right to Buy)	$15.84	M	14431.00	Disposed	2029-02-05	Common Stock (14431.00)	Direct
2021-12-03	Stock Option (Right to Buy)	$10.80	M	21781.00	Disposed	2028-09-27	Common Stock (21781.00)	Direct
2021-12-06	Stock Option (Right to Buy)	$15.84	M	5881.00	Disposed	2029-02-05	Common Stock (5881.00)	Direct
2021-12-06	Stock Option (Right to Buy)	$10.80	M	11126.00	Disposed	2028-09-27	Common Stock (11126.00)	Direct

Footnotes

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2: Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.

F3: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.

F4: Represents the weighted average sale price of the shares sold ranging from $40.00 to $40.92 per share, inclusive.

F5: Represents the weighted average sale price of the shares sold ranging from $41.09 to $41.79 per share, inclusive.

F6: Represents the weighted average sale price of the shares sold ranging from $42.10 to $42.36 per share, inclusive.

F7: Represents the weighted average sale price of the shares sold ranging from $40.00 to $40.35 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) through (7).

F8: 25% of the 299,748 shares underlying the option vested in an annual installment on February 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.

F9: 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.